Simple and Sensitive Titrimetric and Spectrophotometric Determination of Enalapril Maleate in Pharmaceuticals using Permanganate
More details
Hide details
Department of Chemistry, University of Mysore, Manasagangotri, Mysore-57006, India
Publish date: 2017-10-27
Eurasian J Anal Chem 2010;5(2):112–125
Two titrimetric and two spectrophotometric methods are described for determination of enalapril maleate (ENP) in pure drug as well as in tablets. In tirimetry, ENP was quantified by either direct oxidation of ENP content with potassium permanganate in H2SO4 medium (method A) or oxidation of ENP by a known excess of potassium permanganate in H2SO4 medium followed by determination of unreacted permanganate by titration with ferrous ammonium sulphate (method B). In both the methods, the reaction stiochiometry is found to be 1:2 (ENP: KMnO4) and the methods are applicable over the 1.0-10.0 mg. In spectrophotometry, ENP was quantified based on the reduction of potassium permanganate by ENP either in neutral medium (method C, λmax at 340 nm) or in H2SO4 medium (method D, lmax at 550 nm). Under optimum conditions, ENP could be quantified in the concentration ranges, 2.0-12.0 µg mL-1 and 7.0-70.0 µg mL-1 by method C and method D, respectively. The calculated molar absorptivities are 1.8 x 104 and 3.8 x 103 L mol-1 cm-1 for method C and method D, respectively with corresponding Sandell sensitivity values of 0.028 and 0.115 µg cm-2. The limits of detection (LOD) and quantification (LOQ) have also been reported. Accuracy and precision for the assay were determined by calculating the intra-day and inter-day at three concentrations; the intra-day RSD was < 2.60 % and the accuracy was better than 2.80 % (RE). The interference due to common excipients present in the formulations in method A was successfully overcome by extraction with acetone. No interferences was observed from the excipients present in the formulations in method B, method C and method D. The methods were successfully applied to the determination of ENP in tablets and the results were statistically compared with those of a reference method by applying the Student’s t-test and F-test. The accuracy and validity of the methods were ascertained by recovery studies via standard addition technique.
Kanakapura Basavaiah   
Department of Chemistry, University of Mysore, Manasagangotri, Mysore-57006, India
1. Ferguson R K, Vlasses P H, Swanson B N, Majaverian P, Hichenes M and Irvin J D (1982) Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clin Pharmacol Ther 32: 48.
2. The United States Pharmacopoeia 24, 2000, The National Formulary, 19 Rockville, USP Convention.
3. The European Pharmacopoeia [1420], 3rd ed., 2001, Council of European, Strasbourg.
4. Prasad C V N, Saha R N and Parimoo P (1999) Simultaneous determination of amlodipine–enalapril maleate and amlodipine–lisinopril in combined tablet preparations by derivative spectrophotometry. Pharm Pharma Comm 5: 383.
5. Carlucci G, Di Giuseppe E and Mazzeo P (1993) Simultaneous determination of enalapril maleate and hydrochlorothiazide in tablets by derivative UV spectrophotometry and high-performance liquid chromatography. Int J Pharm 93: 245.
6. El Walily A F M, Belal S F, Heaba E A and El Kersh A (1995) Simultaneous determination of enalapril maleate and hydrochlorothiazide by first-derivative ultraviolet spectrophotometry and high-performance liquid chromatography. J Pharm Bio Med Anal 13: 851.
7. Bonazzi D, Gotti R, Andrisano V and Cavrini V (1997) Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC) J Pharm Biomed Anal 16: 431.
8. Shetkar P B and Shinde V M (1997) Simultaneuous determination of enalpril maleate and hydrochlorothiazide in tablets by reversed phase HPLC. Anal Lett 30: 1143.
9. Qin X Z, DeMarco J, and Ip D P (1995) Simultaneous determination of enalapril, felodipine and their degradation products in the dosage formulation by reversed-phase high-performance liquid chromatography using a spherisorb C8 column. J Chromatogr A 707: 245.
10. Pisarev V V, Moskaleva N E, Zverkov Y B, Smirnova L B, Belolipershaya V G and Sukhanov Y V (2005) HPLC/MS determination of enalapril and enalaprilat in the blood plasma. Pharm Chem J 39: 104.
11. Shioya H, Shimojo M, and Kawahara Y (1992) Determination of enalapril and its active metabolite enalaprilat in plasma and urine by gas chromatography/mass spectrometry. Biomed Chromatogr 6: 59.
12. Thomas B R and Ghodbane S (1993) Evaluation of a mixed micellar electrokinetic capillary electrophoresis method for validated pharmaceutical quality control. J Liq Chromatrogr 16: 1983.
13. Aboul-Enein H Y, Bunacin A A, Bala C and Fleschin S (1997). Enalapril and ramipril selective membranes. Anal Lett 30: 1999.
14. Aboul-Enein H Y, Stefan R I and Van-Staden J F (1999). Potentiometric enantioselective membrane electrode for s-enalapril assay. Analusis 27: 53.
15. Matalka K, Arafat T, Hamad M and Jehanli A (2002). Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis. Fundam Clin Pharmacol 16: 237.
16. Baraka M M, El-Sadek M, Moussa E M, Abd-Alaty N M (2008) Spectrophotometric and atomic absorption determination of ramipril, enalapril maleate and lisinopril through ternary complex formation with molybdenum (V)-thiocyanate (Mo(V)-SCN). Chem Pharm Bull 56: 1521.
17. Ayad M M, Shalaby A A, Abdellatef H E, Hosny M M (2002) Spectrophotometric and AAS determination of ramipril and enalapril through ternary complex formation. J Pharm Biomed Anal 28: 311.
18. Abdel R O, Belal S F, Bedair M M, Barakat N S and Haggag R S (2003) Spectrophotometric and polarographic determination of enalapril and lisinopril using 2, 4-dinitrofluorobenzene J Pharma Biomed Anal 31: 701.
19. Rahman N and Haque S M (2008) Optimized and validated spectrophotometric methods for the determination of enalapril maleate in commercial dosage forms. Anal Chem Insights 3: 31.
20. Magda M A, Shalaby A, Abdellatef H E and Hosny M M (2003) Spectrophotometric methods for determination of enalapril and timolol in bulk and in drug formulations. Anal Bioanal Chem 375: 556.
21. Salah M B, Heba H A, Fawzy A E and Shaalan R A (2000) Spectrophotometric determination of enalapril maleate and ramipril in dosage forms. Spectroscopy Letters 33: 91.
22. A I Vogel (1961) A Text Book of Quantitative Inorganic Analysis., 3rd edn., The English Language Book Society and Longman, England, p 280.
23. Semaan F S, Nogueira P A and Cavalheiro E T G (2008) Flow injection spectrophotometric determination of furosemide in pharmaceuticals by the bleaching of a permanganate carrier solution. Anal Lett 41: 66.
24. Emara S (2004) Determination of methotrexate in pharmaceutical formulations by flow injection analysis exploiting the reaction with potassium permanganate. Il Farmaco 59: 827.
25. Rahman N, Ahmad Y and Azmi S N H (2004) Kinetic spectrophotometric method for the determination of norfloxacin in pharmaceutical formulations. Eur J Pharm Biopharm 57: 359.
26. Abdellatef H E (2002) Kinetic spectrophotometric determination of tramadol hydrochloride in pharmaceutical formulation. J Pharm Biomed Ana 29: 835.
27. Al-Tamrah S A (1999) Spectrophotometric determination of nicotine. Anal Chim Acta 379: 75.
28. Sugathi A, Sivakumar H B, Vijayakumar S C, Ravimathi P and Ravi T K (2006) Visible spectrophotometric determination of valdecoxib in tablet dosage forms Ind. J Pharm. Sc 68: 373.
29. IM Kolthoff and R Belcher (1957) Volumetric Analysis- Volume III, Interscience Publishers, Inc., New York.39.
30. IM Kolthoff and R Belcher (1957) Volumetric Analysis- Volume III, Interscience Publishers, Inc., New York.34.
31. International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.
32. J N Miller and Miller J.C., Statistics and chemometrics for analytical chemistry, (2000) Pearson Education Limited: England.
33. SHABIR, G.A. (2003) Validation of high-performance liquid chromatography methods for pharmaceutical analysis: understanding the differences and similarities between validation requirements of the US food and drug administration, the US Pharmacopeia and the international conference on harmonization. J Chromatogr A 987 57.